Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07390890 · ClinicalTrials.gov registry record
DSLT for Reducing Medication in Glaucoma
A clinical trial of Ocular Hypertension and Primary Open Angle Glaucoma, sponsored by The Eye Institute of West Florida.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT07390890 is a study of Ocular Hypertension and Primary Open Angle Glaucoma that is actively recruiting participants, run by The Eye Institute of West Florida. The registered enrollment target is 60 participants, below the 277-participant average among 54 other Ocular Hypertension trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07390890, a study of Ocular Hypertension and Primary Open Angle Glaucoma, is actively recruiting participants, sponsored by The Eye Institute of West Florida.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, single arm, open label study conducted at a single site to evaluate the efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in reducing medication burden in patients with medically controlled ocular hypertension or primary open angle glaucoma. The study will assess the primary endpoint of reduction in medication count at 6 months compared to baseline. Secondary endpoints include IOP reduction compared to baseline (both percentage and absolute), complete success rate (no increase in IOP without medications), proportion of eyes needing medication at 6 months, and any secondary surgical interventions at 6 months post-DSLT. Participants will undergo DSLT with 120 shots, 400 µm spot size, and 1.8mJ fixed energy delivered at the limbus over 2.4 seconds. Follow-up visits will occur at 1 month, 3 months, and 6 months post-procedure, with IOP measured using a calibrated Goldmann tonometer.
Conditions Studied
Interventions
- DEVICE Voyager DSLT
Study Locations (1)
Florida
- The Eye Institute of West Florida - Largo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-26 |
| Est. Completion | 2027-01-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07390890
The ClinicalTrials.gov registry entry for NCT07390890 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 54 other Ocular Hypertension trials with a reported enrollment target (78% lower). The listed sponsor is The Eye Institute of West Florida, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ocular Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Voyager DSLT is the first listed.
NCT07390890 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07390890 about?
NCT07390890 is a clinical study titled "DSLT for Reducing Medication in Glaucoma". This is a prospective, single arm, open label study conducted at a single site to evaluate the efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in reducing medication burden in patients with medically controlled ocular hypertension or primary open angle glaucoma. The study will assess the ...
What is the current status of trial NCT07390890?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2026-02-26. Estimated completion is 2027-01-26.
What conditions does trial NCT07390890 study?
This clinical trial studies the following conditions: Ocular Hypertension, Primary Open Angle Glaucoma.
What interventions are being tested in trial NCT07390890?
The interventions under investigation include: Voyager DSLT (DEVICE).
Who is sponsoring clinical trial NCT07390890?
This trial is sponsored by The Eye Institute of West Florida, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07390890 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ocular Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RECRUITING · Phase 4
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
-
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
RECRUITING · Phase 1
-
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 1
-
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.